ARCHIVES

FDA Approves Gilotrif Tablets in NSCLC, Boehringer Ingelheim’s First Approved Cancer Drug

This article is from The Cancer Letter archive.

Vol. 36 No. 7 | July 26, 2013

Download PDF Visit The Full Archive

Related Articles

Includes May issue of Business & Regulatory Report.

May 31, 2002

Contract Proposal Would Assess Outcomes Other Than Incidence, Response, Mortality

September 18, 1987

NIH, Lasker Foundation Offer Clinical Research Opportunity

December 10, 2010

Study Finds No Benefit for Frequent CA125 Testing in Recurrent Ovarian Cancer

June 5, 2009

ASCO Sees Efforts Pay Off In Health Care Reform: Clinical Trials

October 1, 1993

Digital Microscope Blood Test Identifies Circulating Tumor Cells

February 24, 2012